Actas Dermo-Sifiliograficas, published by Elsevier España, stands as a pivotal resource in the realms of dermatology, histology, and pathology and forensic medicine. With its ISSN of 0001-7310 and E-ISSN 1578-2190, this esteemed journal has transitioned to an Open Access model since 2020, facilitating broader dissemination of impactful research. Operating from its Madrid headquarters, it has been a vital platform for scholarly exchange since its inception in 1945, continuing through its converged years until 2024. The journal holds a Q3 ranking in dermatology, histology, and pathology and forensic medicine as of 2023, reflecting its relevance in the academic community where it ranks 79th in dermatology and 126th in pathology among its peers. With a commitment to advancing knowledge and practice in its fields, Actas Dermo-Sifiliograficas serves as an essential repository for researchers, professionals, and students seeking to engage with the latest findings and innovative perspectives in skin and disease research.

Dermatology Research and Practice is a premier open access journal published by HINDAWI LTD, dedicated to advancing the field of dermatology since its establishment in 2009. With a respectable impact factor and a ranking of #42 out of 142 in the Scopus Medicine - Dermatology category, the journal stands in the 70th percentile, reflecting its influence and relevance in contemporary dermatological research. Based in Egypt, it provides a platform for groundbreaking studies that shape clinical practice and policy worldwide. The journal covers a wide range of topics within dermatology, including but not limited to clinical research, epidemiology, and patient care, making it an essential resource for researchers, healthcare professionals, and students seeking to enhance their understanding and contribute to the field. Emphasizing open access, Dermatology Research and Practice ensures that vital research findings are readily available to the global community, fostering collaboration and innovation in dermatology.

Journal of Drugs in Dermatology, an esteemed publication in the field of dermatology, serves as a vital resource for researchers, clinicians, and healthcare professionals dedicated to advancing knowledge and practices in skin-related therapies and treatments. Established in 2002 and published in the United States, this journal focuses on a wide range of topics pertinent to dermatological pharmacology and therapeutics, reflecting contemporary scientific advancements and innovative approaches to patient care. With a strong presence in Scopus rankings, situating it at rank #73 within the dermatology category, and achieving a commendable Q2 quartile classification in both dermatology and general medicine categories, the journal is committed to enhancing understanding of drug efficacy and safety in dermatological conditions. While the journal maintains a traditional access model, its impact factor underscores its significance in the research community, supporting the ongoing dialogue between academia and clinical practice. We invite professionals and students alike to explore the latest findings and contribute to the progressive discourse on dermatological treatments through this important publication.

CUTIS is a distinguished journal devoted to advancing the field of dermatology and related medical disciplines. Published by Quadrant HealthCom Inc, this journal has been a critical resource since its inception in 1970, traversing the landscape of skin health and medical practice through its engaging articles and research. With an ISSN of 0011-4162 and an E-ISSN of 2326-6929, CUTIS is indexed in Scopus, where it currently holds a rank of #101/142 in the Dermatology category, placing it in the 29th percentile, further affirming its relevance within the academic community. Although it is classified within the Q3 quartile in both Dermatology and Medicine (miscellaneous), CUTIS remains committed to publishing high-quality research that encompasses both innovative treatments and essential dermatological knowledge. The journal serves as an invaluable platform for researchers, practitioners, and students alike, providing critical insights and fostering discussions that enhance patient care and professional practice in the dermatology field.

The Indian Dermatology Online Journal, an esteemed publication of Wolters Kluwer Medknow Publications, serves as a vital resource in the fields of Dermatology, Immunology, Infectious Diseases, and Medical Microbiology. Since transitioning to an Open Access model in 2010, this journal has democratized access to high-quality research and innovative initiatives within these disciplines. With an impact factor positioned in the Q3 category for 2023 across multiple areas, it reflects a commitment to advancing scientific knowledge and practice. Researchers and clinicians benefit from the rigorously peer-reviewed articles, which cover a broad scope of topics relevant to contemporary challenges in dermatology and its related fields. Citing impressive Scopus rankings and broad accessibility options, The Indian Dermatology Online Journal is vital for professionals seeking the latest developments and peer insights to enhance their expertise and improve patient outcomes.

The American Journal of Clinical Dermatology, published by Adis International Ltd, is a leading peer-reviewed journal dedicated to advancing the field of dermatology. With a notable impact factor and a prestigious Q1 rank in both Dermatology and Miscellaneous Medicine categories, this journal stands out as a valuable resource for researchers and clinicians alike, offering cutting-edge insights into clinical practice and innovative treatment strategies. Its comprehensive scope encompasses a broad range of topics within dermatology, addressing both common and rare conditions, with a focus on emerging therapies and technologies. As it converges its publication years from 2000 to 2024, the journal remains an essential platform for disseminating high-quality research to professionals striving to improve patient care and outcomes. With the ISSN 1175-0561 and E-ISSN 1179-1888, the American Journal of Clinical Dermatology facilitates greater accessibility to pivotal findings within the field, making it an indispensable resource for anyone involved in dermatological research and practice.

The Journal of Cosmetic and Laser Therapy, published by TAYLOR & FRANCIS INC in the United Kingdom, serves as a vital resource for professionals, researchers, and students in the fields of dermatology, surgery, and cosmetic medicine. Since its inception in 1999, this peer-reviewed journal has sought to advance knowledge and practice in the burgeoning fields of cosmetic and laser treatments, offering a platform for scholarly articles that explore novel techniques, clinical outcomes, and emerging trends. With an impressive categorization in the 2023 Quartiles showcasing its influence—Q3 in Dermatology and Medicine, and Q2 in Surgery—the journal reflects a commendable impact within the community. Although not an Open Access journal, it provides access to essential information and rigorous research that aids in the development and refinement of treatment protocols. The Scopus ranks further emphasize its significance, particularly in Medicine and Surgery, where it holds positions in the 57th and 52nd percentiles respectively—underscoring its commitment to quality and relevance. As the landscape of cosmetic treatments continues to evolve, the Journal of Cosmetic and Laser Therapy remains an indispensable reference for those looking to stay at the forefront of advancements in this dynamic field.

EXPERIMENTAL DERMATOLOGY, published by WILEY, is a leading journal in the fields of Biochemistry and Dermatology, with impressive rankings including Q1 status in both categories as of 2023. With its ISSN 0906-6705 and E-ISSN 1600-0625, the journal offers a reputable platform for disseminating cutting-edge research and insights into skin biology and related health issues. As a pivotal resource for professionals, researchers, and students alike, EXPERIMENTAL DERMATOLOGY includes a broad scope of topics, fostering a deeper understanding of dermatological conditions and enhancing new therapeutic strategies. The journal’s distinguished performance is highlighted by its Scopus rankings, which place it at the 91st percentile in Medicine-Dermatology and the 65th in Biochemistry. While not an open-access publication, the journal remains committed to ensuring the accessibility of crucial developments within the dermatological community worldwide, facilitating the advancement of both clinical practice and academic inquiry.

The Journal of Dermatology, published by Wiley, is a premier academic journal dedicated to advancing the field of dermatology, with its esteemed reputation reflected in its Q1 ranking in Dermatology and a remarkable Q2 ranking in Miscellaneous Medicine as of 2023. Since its inception in 1974, the journal has become a vital resource for researchers, clinicians, and students alike, covering pioneering studies and cutting-edge advancements in skin health and disease. With a Scopus rank of #32 out of 142 in the Dermatology category, placing it in the 77th percentile, the journal underscores its commitment to fostering knowledge and innovation within the dermatological community. Although the journal operates under a subscription model, it remains an essential platform for disseminating impactful research that shapes clinical practice and enhances patient care. For anyone invested in dermatological sciences, Journal of Dermatology serves as a key publication where critical insights and developments are regularly showcased.

Annals of Dermatology is a prestigious academic journal published by the Korean Dermatological Association, focusing on the latest research and advancements in the field of dermatology. With a commitment to advancing knowledge in skin health and disease, this journal serves as a vital resource for researchers, clinicians, and students working in dermatology and related disciplines. Since its inception in 1989, it has evolved to consolidate its position in the academic community, boasting a Q2 ranking in the 2023 Dermatology category and a Scopus rank of #87 out of 142, placing it in the 39th percentile. Although it operates under a subscription model, the journal's impact factor reflects its significance in advancing dermatological research, attracting innovative studies and reviews that shape clinical practice. With a publication history extending from 1989 to 1996 and then from 2008 to the present, Annals of Dermatology continues to be an essential publication for those devoted to improving skin health.